Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating megestrol acetate for chronic oral food refusal in children has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Megestrol acetate (megestrol acetate)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Feeding Behavior, Feeding Disorder of Infancy or Early Childhood | Phase 4 | Status: COMPLETED | Results posted: 2025-09-10